Taysha Gene Therapies: Rett Syndrome Data Makes This A Must Watch (NASDAQ:TSHA)

Test tubes in clinic, pharmacy and medical research laboratory and new chemical substances

nuttapong punna/iStock via Getty Images

Taysha Gene Therapies (NASDAQ:TSHA) has made great progress recently in advancing its gene therapy known as TSHA-102 for the treatment of patients with Rett Syndrome. Despite only having data from one patient so

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *